We used western blotting to measure TLR4, MyD88 and NF-κB expression, and the findings revealed that their expression levels were greater in the IBD group than in the control group, which was consistent with the results of other DSS-induced mouse models [51]. Here, NFKB1 is linked to inflammatory bowel disease.